|
|
|
 |
|
 |
|
| ND-07 is new drug candidate to target Inflammatory Bowel Disease (IBD) and pancreatitis (acute, chronic) through anti-inflammatory, and cell protection effects. Also ND-07 is designed to decrease side effects common in existing anti-inflammatory drugs. Pre-clinical testing and optimization of ND-07 are now under way. | | | |
|
 |
|
 | |
| |
|
|
|
|
|
| |
| |
ND-07 Development Road Map | | |
|
|
|
| | |
|
|
|
|
|
|
